COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX)

CUSIP: 19243B102

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
87,819,638
Total 13F shares
4,253,980
Share change
-1,040,913
Total reported value
$1,990,924
Price per share
$0.47
Number of holders
39
Value change
-$2,451,158
Number of buys
15
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 19243B102?
CUSIP 19243B102 identifies CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) as of Q3 2024

As of 30 Sep 2024, COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,253,980 shares. The largest 10 holders included VANGUARD GROUP INC, Alyeska Investment Group, L.P., GEODE CAPITAL MANAGEMENT, LLC, CM Management, LLC, AMERICAN FINANCIAL GROUP INC, UBS Group AG, Sigma Planning Corp, Kestra Advisory Services, LLC, BlackRock, Inc., and ACADIAN ASSET MANAGEMENT LLC. This page lists 39 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.